EFEnrique Flores-Gasca

Enrique Flores-Gasca

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Enrique Flores-Gasca has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Surgical Isolation of a Haemonchus contortus FESC Strain: Morphological and Molecular Characterization for Use in Research

    by César Cuenca-Verde, Rosa Isabel Higuera-Piedrahita, Héctor Alejandro de la Cruz-Cruz, Enrique Flores-Gasca, María del Rocio Morales-Méndez, Marco Antonio Muñoz-Guzmán, Fernando Alba-Hurtado, Jorge Alfredo Cuéllar-Ordaz

    Haemonchus contortus is one of the most prevalent gastrointestinal nematodes in all ecosystems in Mexico, where sheep are raised on pasture, and it poses a significant threat. This study aimed to examine the surgical isolation of a Mexican H. contortus strain, its morphological and molecular characterization, and the maintenance of this strain for future research. Biological behavior and some phenotypic aspects of the adults were considered. Fecal samples were obtained from naturally infected sheep, larval cultures were performed, and a nematode-free lamb was infected. Once the infection was established, the donor sheep were euthanized, the adults recovered, and H. contortus females and males were selected. A surgical transfer from H. contortus adult to the abomasum of a receptor lamb was performed, and the beginning of the egg excretion was confirmed three days post-transfer; fecal cultures from the receptor lamb were conducted to verify the purity of the strain. After three lambs were infected with 3000, 5000, and 10,000 L3, the pre-patent period, prolificacy, and measurements of the adult stages of the strain were studied. The molecular characteristics were evaluated by qPCR; primers were designed based on NCBI genomic DNA sequences of H. contortus to amplify a 176 bp fragment, and the amplicon was sequenced for taxonomic identification. The results of this study describe biological characteristics and some phenotypic aspects of the adults, as well as eggs and infective larvae, and molecular characteristics of the isolated strain, and establish a successful methodology for isolating and maintaining a pure strain of H. contortus (FESC-strain); it can be used as a reference in experimental infections or anthelmintic resistance studies.

  • Open Access

    Genomic and Plasmid Distribution of Clinically Relevant Antibiotic Resistance Genes in Pets and Free-Roaming Dogs in an Urban Area of Central Mexico

    by María Daniela Frade-Pérez, Rosa Martha Pérez-Serrano, Sergio Francisco Cornelio-Martínez, María Laura González-Dávalos, Yezenia Rubio-Venegas, Enrique Flores-Gasca, Alfredo Varela-Echavarría, María Ofelia Mora-Izaguirre

    Dogs, especially as pets but also an increasing number of stray dogs, share environments with humans, facilitating the transfer of antibiotic resistance genes (ARGs) between genetic compartments, with zoonotic and public health implications that must be addressed within One Health. In this cross-sectional comparative study, we explored the distribution of seven selected clinically relevant ARGs in both genomic DNA (gDNA) and plasmid DNA (pDNA), and the phenotypic resistance profile of the cultivable microbiota, between pet dogs (PeDs, n = 12) and free-roaming dogs (FRDs, n = 10) in Mexico. Tetracycline resistance genes (tetQ, tetW, and tetM) predominated in both compartments (40% to 100%), suggesting the presence of a core tetracycline-associated resistome. In contrast, plasmid-associated differences were group-specific: in pDNA cfxA was enriched in FRDs (90%) and tetK in PeDs (42%), whereas blaTEM-1 and ermC were absent in two dog populations. Cultivable bacteria from both groups exhibited phenotypic multidrug resistance, particularly by β-lactams, macrolides, lincosamides, and tetracyclines. FRDs also harbored pathogenic–zoonotic bacteria such as Yersinia enterocolitica, Campylobacter jejuni, and Enterococcus faecalis. Our findings indicated that FRDs and PeDs harbor substantial resistomes, with differences in plasmid-associated ARGs, revealing a transfer potential related to environmental exposure.

  • Open Access

    In Nulliparous and Multiparous Ovariectomized Goats Is Possible to Induce Maternal Behavior with Hormonal Treatment Plus Vagino-Cervical Stimulation

    by Paolo César Cano-Suárez, Juan Pablo Damián, Rosalba Soto, Karen Guadalupe Ayala-Pereyro, Rocío Ibarra-Trujillo, Laura Castillo-Hernández, Enrique Flores-Gasca, Rocío Morales-Méndez, Jorge Eduardo Mendoza-Flores, Angélica Terrazas

    No studies have induced maternal behavior in goats through hormonal treatment. We evaluated whether ovariectomized goats treated with estradiol benzoate (EB2; n = 7 nulliparous and 10 multiparous goats) or progesterone + estradiol benzoate (P4 + EB2; n = 7 nulliparous and 7 multiparous goats), before or after vagino-cervical stimulation (VCS), displayed maternal behavior. When all goats were measured within treatments, in the EB2 group, low-pitch bleats were more frequent, and the time spent cleaning the kids was longer after VCS (p < 0.01), while location changes were more frequent before VCS. In nulliparous goats, those in the EB2 group emitted more low-pitch bleats after VCS than before (p = 0.04). The frequency of location changes was higher before VCS than after (p = 0.05). In multiparous goats, the frequency of smelling the kids and aggression toward the kids before VCS was higher in the EB2 group than in the P4 + EB2 group (p < 0.01). Within treatments, the EB2 group emitted more low-pitch bleats after VCS than before (p = 0.01), and the duration of cleaning the kids was longer after VCS than before (p = 0.028). Within the P4 + EB2 group, the kids were smelled more frequently after VCS than before (p = 0.03). The maternal index after vagino-cervical stimulation was higher in goats with EB2 (p = 0.002). Nulliparous goats treated with P4 + EB2 had a higher maternal index compared with those treated with EB2 alone (p = 0.04). In conclusion, regardless of parity, maternal behavior induced with the EB2 treatment was better when VCS was applied. Likewise, maternal experience altered the response. In multiparous females, any of the treatments were better after VCS, while in nulliparous females, this was only evident with the EB2 treatment.


  • Open Access

    ¿Es posible usar probióticos para prevenir o tratar la obesidad en perros?

    by María Frade-Pérez, Laura González-Dávalos, Cesar Garzón-Pérez, Enrique Flores-Gasca, Ofelia Mora-Izaguirre

    La obesidad canina es un trastorno metabólico complejo y multifactorial que ha aumentado de forma alarmante en todo el mundo, lo que afecta tanto la salud animal como la salud pública. Más allá de la sobrealimentación y la falta de ejercicio, las investigaciones actuales destacan a la microbiota intestinal como un regulador clave del equilibrio metabólico. Las alteraciones en su composición (como el incremento en la relación Firmicutes/Bacteroidetes, y la pérdida de diversidad microbiana) perturban la absorción de nutrientes, el metabolismo de lípidos y la regulación inmunológica, esto genera un entorno proinflamatorio que favorece la acumulación de grasa. Los probióticos, definidos como microorganismos vivos que promueven la salud al administrarse en cantidades adecuadas, muestran potencial para restaurar el equilibrio intestinal y mejorar el metabolismo del hospedero. Su mecanismo de acción implica reforzar la barrera intestinal, modular la respuesta inmunológica y producir ácidos grasos de cadena corta que regulan el uso energético. Sin embargo, la mayoría de los probióticos comerciales para perros derivan de cepas humanas, no diseñadas específicamente para trastornos metabólicos. Evidencias recientes sugieren que cepas de Lactobacillus, Bifidobacterium y Enterococcus de origen canino pueden reducir la adiposidad y mejorar la salud metabólica. El desarrollo de probióticos específicos para perros podría integrarse a estrategias dietéticas y conductuales sostenibles, dentro del marco “Una Salud” que vincula el bienestar animal y humano. https://doi.org/10.21929/abanicomicrobiano/2025.4 2025-04 https://www.youtube.com/watch?v=OfjG63UUW2s Canine obesity is a complex metabolic disorder that has become increasingly common worldwide, affecting not only animal health but also public health and welfare. Beyond excessive feeding and limited exercise, current research highlights the gut microbiota as a central regulator of metabolic balance. Alterations in its composition (such as an increased Firmicutes/Bacteroidetes ratio, and loss of microbial diversity) disrupt nutrient absorption, lipid metabolism, and immune regulation, creating a pro-inflammatory environment that favors fat accumulation. Probiotics, defined as live microorganisms that promote health when administered in sufficient quantities, have shown potential to restore intestinal balance and improve host metabolism. They act by strengthening the intestinal barrier, modulating immunity, and producing short-chain fatty acids that regulate energy use. However, most commercial probiotics for dogs are adapted from human strains and not specifically developed for metabolic disorders. Emerging evidence suggests that canine-derived strains of Lactobacillus, Bifidobacterium, and Enterococcus may help reduce adiposity and improve metabolic health. Designing next-generation, species-specific probiotics could complement dietary and behavioral interventions, offering a sustainable, microbiota-based strategy to prevent and manage obesity in dogs within the broader “One Health” perspective linking animal and human well-being. https://doi.org/10.21929/abanicomicrobiano/2025.4 2025-04 https://www.youtube.com/watch?v=OfjG63UUW2s

  • Open Access

    Neurobiology of anesthetic-surgical stress and induced behavioral changes in dogs and cats: A review

    by I. Hernández-Avalos, E. Flores-Gasca, D. Mota-Rojas, A. Casas-Alvarado, A. E. Miranda-Cortés, A. Domínguez-Oliva

    The anesthetic-surgical stress response consists of metabolic, neuroendocrine, hemodynamic, immunological, and behavioral adaptations through chemical mediators such as the adrenocorticotropic hormone, growth hormone, antidiuretic hormone, cortisol, aldosterone, angiotensin II, thyroid-stimulating hormone, thyroxine, triiodothyronine, follicle-stimulating hormone, luteinizing hormone, catecholamines, insulin, interleukin (IL)-1, IL-6, tumor necrosis factor-alpha, and prostaglandin E-2. Behavioral changes include adopting the so-called prayer posture, altered facial expressions, hyporexia or anorexia, drowsiness, sleep disorders, restriction of movement, licking or biting the injured area, and vocalizations. Overall, these changes are essential mechanisms to counteract harmful stimuli. However, if uncontrolled surgical stress persists, recovery time may be prolonged, along with increased susceptibility to infections in the post-operative period. This review discusses the neurobiology and most relevant organic responses to pain and anesthetic-surgical stress in dogs and cats. It highlights the role of stress biomarkers and their influence on autonomous and demeanor aspects and emphasizes the importance of understanding and correlating all factors to provide a more accurate assessment of pain and animal welfare in dogs and cats throughout the surgical process.